161 related articles for article (PubMed ID: 37307881)
1. Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion.
Torricelli F; Santandrea G; Botti C; Ragazzi M; Vezzani S; Frasoldati A; Ghidini A; Giordano D; Zanetti E; Rossi T; Nicoli D; Ciarrocchi A; Piana S
Mod Pathol; 2023 Sep; 36(9):100244. PubMed ID: 37307881
[TBL] [Abstract][Full Text] [Related]
2. Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.
Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
[TBL] [Abstract][Full Text] [Related]
3. Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.
Censi S; Galuppini F; Clausi C; Battheu F; Manso J; Piva I; Corvaglia S; Pedron MC; Mondin A; Iacobone M; Torresan F; Merante Boschin I; Bertazza L; Barollo S; Pennelli G; Mian C
Thyroid; 2024 Feb; 34(2):177-185. PubMed ID: 38047536
[No Abstract] [Full Text] [Related]
4. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
Viswanathan K; Behrman DB; Lubin DJ
Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
[TBL] [Abstract][Full Text] [Related]
5. External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.
Vissio E; Maletta F; Fissore J; Osella Abate S; Retta F; Brizzi MP; Piovesan A; Rossetto Giaccherino R; Volante M; Papotti M
Endocr Pathol; 2022 Sep; 33(3):359-370. PubMed ID: 35583706
[TBL] [Abstract][Full Text] [Related]
6. International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience.
Rai V; Saha A; Mehta S; Shah RA; Trivedi P; Samanta ST; Rathod P; Manimaran P
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1571-1579. PubMed ID: 38010402
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Risk Stratification of 2526 Medullary Thyroid Carcinoma Patients: A Study Based on Surveillance, Epidemiology, and End Results Database.
Le MK; Kawai M; Odate T; Vuong HG; Oishi N; Kondo T
Endocr Pathol; 2022 Sep; 33(3):348-358. PubMed ID: 35852678
[TBL] [Abstract][Full Text] [Related]
8. Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.
Williams JF; Zhao M; Najdawi F; Ahmadi S; Hornick JL; Wong KS; Barletta JA
Endocr Pathol; 2022 Sep; 33(3):371-377. PubMed ID: 35553368
[TBL] [Abstract][Full Text] [Related]
9. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.
Jung CK; Agarwal S; Hang JF; Lim DJ; Bychkov A; Mete O
Endocr Pathol; 2023 Mar; 34(1):1-22. PubMed ID: 36890425
[TBL] [Abstract][Full Text] [Related]
10. Exploration of Digital Image Analysis for Ki67 Quantification in the Grading of Medullary Thyroid Carcinoma: A Pilot Study with 85 Cases.
Behrman DB; Lubin DJ; Magliocca K; Shi Q; Viswanathan K
Head Neck Pathol; 2023 Sep; 17(3):638-646. PubMed ID: 37294412
[TBL] [Abstract][Full Text] [Related]
11. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
Xu B; Fuchs TL; Ahmadi S; Alghamdi M; Alzumaili B; Bani MA; Baudin E; Chou A; De Leo A; Fagin JA; Ganly I; Glover A; Hartl D; Kanaan C; Khneisser P; Najdawi F; Nigam A; Papachristos A; Repaci A; Spanheimer PM; Solaroli E; Untch BR; Barletta JA; Tallini G; Al Ghuzlan A; Gill AJ; Ghossein RA
J Clin Oncol; 2022 Jan; 40(1):96-104. PubMed ID: 34731032
[TBL] [Abstract][Full Text] [Related]
12. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
[No Abstract] [Full Text] [Related]
13. Prognostic value of numbers of metastatic lymph node in medullary thyroid carcinoma: A population-based study using the SEER 18 database.
Meng K; Luo H; Chen H; Guo H; Xia W
Medicine (Baltimore); 2019 Jan; 98(1):e13884. PubMed ID: 30608412
[TBL] [Abstract][Full Text] [Related]
14. High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.
Simbolo M; Mian C; Barollo S; Fassan M; Mafficini A; Neves D; Scardoni M; Pennelli G; Rugge M; Pelizzo MR; Cavedon E; Fugazzola L; Scarpa A
Virchows Arch; 2014 Jul; 465(1):73-8. PubMed ID: 24828033
[TBL] [Abstract][Full Text] [Related]
15. Grading system for medullary thyroid carcinoma; an institutional experience.
Podany P; Meiklejohn K; Garritano J; Holt EH; Barbieri A; Prasad M; Gilani SM
Ann Diagn Pathol; 2023 Jun; 64():152112. PubMed ID: 36736129
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive markers in medullary thyroid carcinoma.
Erovic BM; Kim D; Cassol C; Goldstein DP; Irish JC; Asa SL; Mete O
Endocr Pathol; 2012 Dec; 23(4):232-42. PubMed ID: 23150029
[TBL] [Abstract][Full Text] [Related]
18. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.
Fuchs TL; Nassour AJ; Glover A; Sywak MS; Sidhu SB; Delbridge LW; Clifton-Bligh RJ; Gild ML; Tsang V; Robinson BG; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
Am J Surg Pathol; 2020 Oct; 44(10):1419-1428. PubMed ID: 32452872
[TBL] [Abstract][Full Text] [Related]
19. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA; Nosé V; Sadow PM
Endocr Pathol; 2021 Mar; 32(1):35-43. PubMed ID: 33492588
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas.
Najdawi F; Ahmadi S; Capelletti M; Dong F; Chau NG; Barletta JA
Histopathology; 2021 Sep; 79(3):427-436. PubMed ID: 33763905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]